OFIX Orthofix Medical Dashboard

Orthofix Medical, Inc. engages in the provision of medical devices. It operates through the following business segments: Global Spine and Global Extremities. The Global Spine reporting segment offers three primary product categories: Bone Growth Therapies, Spinal Implants, and Biologics. The Bone Growth Therapies product category manufactures, distributes, and provides support services of bone growth stimulator devices that enhance bone fusion. The Spinal Implants product category designs, develops, and markets a broad portfolio of motion preservation and fixation implant products used in surgical procedures of the spine. The Biologics product category provides a portfolio of regenerative products and tissue forms that allow physicians to treat a variety of spinal and orthopedic conditions. The Global Extremities reporting segment offers products and solutions that allow physicians to successfully treat a variety of orthopedic conditions unrelated to the spine. The company was founded on October 19, 1987 and is headquartered in Lewisville, TX.

Company profile

Ticker

OFIX

Exchange

NASDAQ

Website

www.orthofix.com

CEO

Jon C. Serbousek

Location

Texas

Fiscal year end

Dec 31

Sector

Manufacturing > Surgical and Medical Instrument Manufacturing

Industry (SIC)

Surgical & Medical Instruments & Apparatus

Boston Scientific • Baxter International • Becton, Dickinson And • 3M • Stryker • Teleflex • Resmed • Hill-Rom • Integra Lifesciences • Nuvasive ...

Former names

ORTHOFIX INTERNATIONAL N V

SEC CIK

0000884624

Corporate docs

Articles of Incorporation & Bylaws

OFIX stock data

S&P 500

1M 1Y 2Y 5Y

News

Pro users get this 30m faster

Orthofix Announces FDA Clearance And Initial Patient Implant Of Company's 3D-Printed Titanium Cervical Spacer System With Nanovate Technology

5 Apr 21

Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and extremities focus, today announced the U.S. Food and Drug Administration (FDA) 510(k) clearance and the first patient implant of the

Orthofix Medical Q4 Adj. EPS $0.44 Beats $0.19 Estimate, Sales $117.60M Beat $113.94M Estimate

26 Feb 21

Orthofix Medical (NASDAQ:OFIX) reported quarterly earnings of $0.44 per share which beat the analyst consensus estimate of $0.19 by 131.58 percent. This is a 13.73 percent decrease over earnings of $0.51 per share from

Earnings Scheduled For February 26, 2021

26 Feb 21

Companies Reporting Before The Bell • Ryman Hospitality Props (NYSE:RHP) is projected to report quarterly loss at $1.88 per share on revenue of $106.90 million.

The Daily Biotech Pulse: Merck Goes Shopping, Decision Day For Sarepta, Pfizer, Moderna Unveil Vaccine Strategies For Coronavirus Variants

25 Feb 21

Stocks That Hit 52-Week Highs On Wednesday

24 Feb 21

Press releases

Pro users get this 30m faster

Orthofix Announces Board Chair Transition

7 Apr 21

Ron Matricaria to Conclude Service as Chairman of Orthofix Board of Directors Catherine Burzik to be Nominated for Election at the 2021 Annual Meeting Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device

Orthofix Launches Nationwide Recycling Program to Improve Sustainability

10 Mar 21

Orthofix is the first and only company in the U.S. to offer a free recycling program to its bone growth therapy patients Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and extremities

Orthofix Reports Fourth Quarter and Fiscal Year 2020 Results

26 Feb 21

Fourth quarter net sales of $117.6 million, within 3% of our 2019 results US Spine implant sales grew 11% compared to fourth quarter 2019, driven by record M6-C artificial cervical disc performance Strong cash flow

Orthofix Medical, Inc. to Host Earnings Call

26 Feb 21

Orthofix to Present at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Virtual Conference on February 19

11 Feb 21

Calendar

26 Feb 21

17 Apr 21

31 Dec 21

Financial summary

Financial statements Chart OFIX financial data

Quarter (USD)	Dec 20	Sep 20	Jun 20	Mar 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Dec 20	Dec 19	Dec 18	Dec 17
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from company earnings reports.

Cash burn rate (estimated)	Burn method: Change in cash		Burn method: Operating income/loss		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	96.82M	96.82M	96.82M	96.82M	96.82M	96.82M
Cash burn (monthly)	(positive/no burn)	(positive/no burn)	(positive/no burn)	276.25K	(positive/no burn)	(positive/no burn)
Cash used (since last report)	n/a	n/a	n/a	984.65K	n/a	n/a
Cash remaining	n/a	n/a	n/a	95.84M	n/a	n/a
Runway (months of cash)	n/a	n/a	n/a	346.9	n/a	n/a

Beta Read what these cash burn values mean

Recent insider trades

OFIX insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
2 Apr 21	Elting Kimberley A.	Common Stock	Payment of exercise	Dispose F	No	No	42.93	335	14.38K	44,217
2 Apr 21	Doug Rice	Common Stock	Payment of exercise	Dispose F	No	No	42.93	363	15.58K	66,478
1 Apr 21	Jon Carl Serbousek	Common Stock	Payment of exercise	Dispose F	No	No	42.93	2,784	119.52K	113,722
1 Apr 21	Jon Carl Serbousek	Common Stock	Grant	Aquire A	No	No	0	40,764	0	116,506
1 Apr 21	Jon Carl Serbousek	Performance Share Units Common Stock	Grant	Aquire A	No	No	0	40,764	0	40,764
1 Apr 21	Kenny Kevin J.	Common Stock	Payment of exercise	Dispose F	No	No	42.93	753	32.33K	30,268
1 Apr 21	Kenny Kevin J.	Common Stock	Grant	Aquire A	No	No	0	12,229	0	31,021
1 Apr 21	Kenny Kevin J.	Performance Share Units Common Stock	Grant	Aquire A	No	No	0	12,229	0	12,229
1 Apr 21	Elting Kimberley A.	Common Stock	Payment of exercise	Dispose F	No	No	42.93	829	35.59K	44,552
1 Apr 21	Elting Kimberley A.	Common Stock	Payment of exercise	Dispose F	No	No	42.93	2,985	128.15K	45,381

Data from 3, 4 and 5 filings. Stock values as filed, not updated for current price.

Institutional ownership Q4 2020

OFIX institutional ownership history Ownership history

Data for the last complete 13F reporting period. To see the most recent changes to ownership, click the ownership history button above.

13F holders	Current	Prev Q	Change
Total holders	0	0
Opened positions	0	0
Closed positions	0	0
Increased positions	0	0
Reduced positions	0	0

13F shares	Current	Prev Q	Change
Total value	0	0
Total shares	0	0
Total puts	0	0
Total calls	0	0
Total put/call ratio	–	–	–

Largest owners	Shares	Value	Change

Largest transactions	Shares	Bought/sold	Change

Data from 13F filings. Stock values as filed, not updated for current price. Long positions only.

Financial report summary

Competition

Medtronic • Stryker • Fuse Medical • Track • Zimmer Biomet • Nuvasive • Globus Medical • Xtant Medical • Wright Medical • Medtronic

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Avg

New words: Academy, accessory, adult, aid, alike, arthroplasty, Beaming, belief, blood, broaden, burden, cadence, Calcaneal, cancellation, carryforward, chain, Charcot, CHF, closure, CMSA, condensed, consumer, contemplated, content, correctly, counterparty, crucial, deferral, deploying, digital, disclaim, dissemination, dissipated, distancing, downtime, duty, dynamization, economy, entertainment, environment, expressly, factual, forefront, franchise, fundraising, geography, goal, heightening, HHS, IDE, implied, inaccurate, incurrence, infection, inorganic, interim, journey, JuniOtho, lacking, led, lifelong, lingering, live, magnitude, malware, micromotion, mid, Military, myHEXplan, mySuperheroAcademy, Neo, niche, orthobiologic, OrthoNext, Orthopaedic, OSCAR, outpatient, owed, pandemic, panel, pathway, pattern, Paul, penetration, Pennig, people, permanent, philosophy, pioneer, precautionary, prepayment, pronounced, proximal, putty, Rehabilitation, Reinforcement, reinstated, relaxed, relief, reopen, repaid, reproducible, robust, ROU, rulemaking, safe, salary, shelter, show, slight, social, spite, steadily, strip, suddenly, Switzerland, telemetry, thereof, transformation, travel, turn, ultrasonic, underscore, unemployment, vaccinated, vi, wellbeing, wife, winter, wrong

Removed: ACDF, acutely, adjacent, adjust, adolescent, advantage, ALIF, American, amnion, Ascent, assembly, assured, avoiding, Brasil, Breg, building, carried, Centronail, choice, chorion, coating, cold, comment, committed, compatible, configuration, conform, connecting, Connector, consented, consultant, contoured, created, CSA, cylindrical, DAF, delivered, demonstrating, Disciplinary, discontinued, distal, domicile, doubtful, dual, earn, Edugame, enforce, enhanced, escrow, essence, essential, EU, executed, extending, femoral, filler, financially, fit, flex, geared, gold, Gotfried, grip, hand, hard, hardware, height, Hind, holder, hydroxyapatite, improved, indemnified, inflammation, instrument, involving, knock, knowledge, LE, legacy, legally, legislative, linear, Linked, LPS, Ltda, main, mandate, manipulated, meaningful, mesenchymal, Mexican, mineral, MJ, motivational, Niemann, North, notwithstanding, online, opposing, optimize, optimizing, orthotic, percutaneously, pin, placenta, placental, plating, poor, precision, priority, professional, Promeca, proportion, prosthetic, psychologist, ready, reflected, reliably, remove, restatement, revising, rigidity, ring, Rite, save, saving, scar, Scottish, shape, shared, Sheffield, shortly, simplicity, smallest, society, soft, sort, stabilized, stable, steel, Street, subcontracting, sufficiently, superficial, supplied, surface, targeting, tarsometatarsal, taxing, terminating, thousand, thread, threaded, TMT, transferable, transportation, tray, Trochanteric, trust, tutorial, unaudited, undesired, validation, VeroNail, vertebral, viability, visibility, vision, void, Volar, VPS, walking, Water, younger

From filing 10-K 2020 FY